Cross-allergy between penicillins and cephalosporins: a paradigm shift

Authors

  • Liliana Dias Department of Allergy and Clinical Immunology, Unidade I, Centro Hospitalar Vila Nova Gaia/ Espinho https://orcid.org/0000-0003-2285-4333
  • Cláudia Pedrosa Immunoallergology and Pediatric Pulmonology Unit, Department of Pediatrics, Unidade II, Centro Hospitalar Vila Nova de Gaia/Espinho https://orcid.org/0000-0001-6543-879X

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v31.i1.21607

Keywords:

cephalosporin, cross-reactivity, penicillin, side chain

Abstract

Allergic reactions to beta-lactam antibiotics are the most common cause of allergic drug reactions. The incorrect diagnosis prevents patients from receiving a highly effective therapy.

The potential cross-reactivity between penicillin and cephalosporin has very significant therapeutic implications. Penicillins and cephalosporins share a common beta-lactam ring and side chains. A number of studies indicate that the R1 side chain, rather than the ring itself, is the determining factor for cross-reactivity.

Herein is presented a review of the immunologic mechanisms implicated in penicillin and cephalosporin cross-reactivity and a practical approach to the use of cephalosporins in patients allergic to penicillin.

Downloads

Download data is not yet available.

References

Hermanides J, Lemkes BA, Prins JM, Hollmann MW, Terreehorst I. Presumed β-lactam allergy and cross-reactivity in the operating theater: A practical approach. Anesthesiology. 2018;129(2):335-42.

Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: A review. JAMA 2019; 321(2): 188-99.

Bush K, Bradford PA. Β-lactams and β-lactamase inhibitors: An overview. Cold Spring Harbor perspectives in medicine. 2016;6(8): a025247.

Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. The Lancet. 2019;393(10167):183-98.

Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. The American Journal of Medicine 2008; 121(7): 572-6.

Sade K, Holtzer I, Levo Y, Kivity S. The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clinical & Experimental Allergy 2003; 33(4): 501-6.

Macy E, Blumenthal KG. Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?. Journal of Allergy and Clinical Immunology: In Practice 2018; 6(1): 82-9.

Coombs PR, Gell PG. Classification of Allergic Reactions Responsible for Clinical Hypersensitivity and Disease. Clinical Aspects of Immunology, Oxford University Press 1968; 575-96.

Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58(10): 961-72.

Regateiro F, Faria E. Mecanismos imunopatológicos das reações de hipersensibilidade a fármacos. Revista Portuguesa Imunoalergologia 2016;24(2): 63-78.

Blumenthal KG, Shenoy ES, Wolfson AR, Berkowitz DN, Carballo VA, Balekian DS, et al. Addressing inpatient beta-lactam allergies: A multi-hospital implementation. The journal of allergy and clinical immunology: In practice 2017; 5(3): 616-25.

Oliver Hausmann, Drug Allergy. Middleton’s allergy essentials. 1st ed. Elsevier Health Sciences 2017; 225-46.

Caruso C, Valluzzi RL, Colantuono S, Gaeta F, Romano A. Β-lactam allergy and cross-reactivity: A clinician’s guide to selecting an alternative antibiotic. JAA. 2021; 14(31): 31-46.

Barber MS, Giesecke U, Reichert A, Minas W. Industrial enzymatic production of cephalosporin-based beta-lactams. Advances in biochemical engineering, biotechnology 2004; 88: 179-15.

Girard JP. Common antigenic determinants of penicillin G, ampicillin and the cephalosporins demonstrated in men. International Archives of Allergy and Immunology 1968; 33(5): 428-38.

Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: A paradigm shift. Diagnostic Microbiology & Infectious Disease 2007; 57(3): S13-S18.

Romano A, Gaeta F, Poves M, Valluzzi R. Cross-reactivity among beta-lactams. Current Allergy and Asthma Reports 2016; 16(3): 1-12.

Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Annals of Allergy, Asthma & Immunology 2014; 112(5): 404-12.

Khan F, Weiss M. Skin testing for beta-lactam antibiotics: Impact of the availability of a major determinant. Current Allergy Asthma Reports 2013; 13(1): 64-70.

Rosário NA, Grumach AS. Allergy to beta-lactams in pediatrics: A practical approach. Jornal de pediatria 2006; 82(5 Suppl): S181.

Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183-93.

Lee QU. Use of cephalosporins in patients with immediate penicillin hypersensitivity: Cross-reactivity revisited. Hong Kong medical journal 2014; 20(5):428-36.

Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis. Otolaryngology - Head and Neck Surgery 2007; 136(3): 340-7.

Zagursky RJ, Pichichero ME. Cross-reactivity in β-lactam allergy. The Journal of Allergy and Clinical Immunology: In Practice 2018; 6(1): 72-81.

Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183-93.

Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, Friedmann PS, et al. BSACI guidelines for the management of drug allergy. Clinical & Experimental Allergy 2009; 39(1): 43-61.

Pichichero ME. A review of evidence supporting the american academy of pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115(4): 1048-57.

Caubet J, Kaiser L, Lemaître B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge. The Journal of Allergy and Clinical Immunology 2010; 127(1): 218-22.

Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Mujgan F, et al. Parental‐reported drug allergy in 6‐ to 9‐yr‐old urban schoolchildren. Pediatric Allergy and Immunology 2008; 19(1): 82-5.

Lange L, Koningsbruggen SV, Rietschel E. Questionnaire‐based survey of lifetime‐prevalence and character of allergic drug reactions in german children. Pediatric Allergy and Immunology 2008; 19(7): 634-8.

Rebelo GE, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: From self-reporting to confirmed diagnosis. Clinical & Experimental Allergy 2008; 38(1): 191-8.

Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. Journal of antimicrobial chemotherapy. 2007;60(5):1172-3.

Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: A Literature review. Journal of Emergency Medicine 2012; 42(5): 612-20.

Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64(2): 183-93.

Miranda A, Blanca M, Vega JM, Segurado E, Justicia JL, Juarez C. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. The Journal of Allergy and Clinical Immunology 1996; 98(3): 671-7.

Levine BB, Fellner MJ, Levytska V, Franklin EC, Alisberg N. Benzylpenicilloyl-specific serum antibodies to penicillin in man. II. sensitivity of the hemagglutination assay method, molecular classes of the antibodies detected, and antibody titers of randomly selected patients. The Journal of immunology 1966; 96(4): 719.

Atanasković‐Marković M, Veličković TĆ, Gavrović‐Jankulović M, Vučković O, Nestorović B. Immediate allergic reactions to cephalosporins and penicillins and their cross‐reactivity in children. Pediatric allergy and immunology. 2005;16(4):341-7.

Picard M, Robitaille G, Karam F. Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: Two systematic reviews and meta-analyses. The journal of allergy and clinical immunology in practice. 2019;7(8):2722-38.

Farinha S, Cardoso B, Tomaz E, Inácio F. Profiles of sensitization to cephalosporins in clinical practice. Revista Portuguesa Imunoalergologia 2018; 26(4): 263-71.

Kim M, Lee J. Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Allergy, asthma & immunology research. 2014; 6(6): 485-95.

Infarmed. Boletim de fármaco-vigilância. Novos Cadernos NAEA 2010; 14(1): 4.

Mirakian R, Leech SC, Krishna MT, Richter AG, Huber PA, Farooque S, et al. Management of allergy to penicillins and other beta‐lactams. Clinical & Experimental Allergy 2015; 45(2): 300-27.

Blanca LN, Atanaskovic MM, Gomes ER, Kidon M, Kuyucu S, Mori F, et al. An EAACI task force report on allergy to beta‐lactams in children: Clinical entities and diagnostic procedures. Pediatric allergy and immunology. 2021;32(7):1426-36.

Joint Task Force on Practice Parameter, American Academy of Allergy Asthma and Immunology and American College of Allergy Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105: 259–73.

Félix MM, Kuschnir FC. Penicillin allergy: current aspects. Adolescência e Saúde 2011; 8(3): 43-53.

Downloads

Published

2022-04-04

How to Cite

1.
Dias L, Pedrosa C. Cross-allergy between penicillins and cephalosporins: a paradigm shift. REVNEC [Internet]. 2022Apr.4 [cited 2024Mar.28];31(1):31-7. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/21607

Issue

Section

Review Articles

Most read articles by the same author(s)